DHX40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.744400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.948200E-01
Normal-vs-Stage2
3.561200E-01
Normal-vs-Stage3
2.499500E-02
Normal-vs-Stage4
4.047200E-01
Stage1-vs-Stage2
2.000400E-01
Stage1-vs-Stage3
1.045760E-01
Stage1-vs-Stage4
5.502200E-01
Stage2-vs-Stage3
1.295240E-01
Stage2-vs-Stage4
7.376400E-01
Stage3-vs-Stage4
9.502000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.726800E-01
Normal-vs-AfricanAmerican
6.495200E-01
Normal-vs-Asian
2.816200E-01
Caucasian-vs-AfricanAmerican
6.319000E-01
Caucasian-vs-Asian
5.332200E-01
AfricanAmerican-vs-Asian
3.500400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.058800E-01
Normal-vs-Female
4.353200E-01
Male-vs-Female
8.148400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.332000E-01
Normal-vs-Age(41-60Yrs)
9.733600E-01
Normal-vs-Age(61-80Yrs)
2.512800E-01
Normal-vs-Age(81-100Yrs)
9.019500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.613400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.315210E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.984400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.55200000000156E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.217560E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.311400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.885720E-02
Normal-vs-Daily Drinker
4.048400E-01
Normal-vs-Weekly Drinker
1.763770E-01
Normal-vs-Occasional Drinker
9.696600E-01
Normal-vs-Social Drinker
9.202200E-01
Non Drinker-vs-Daily Drinker
2.569000E-01
Non Drinker-vs-Weekly Drinker
5.052000E-01
Non Drinker-vs-Occasional Drinker
1.230300E-02
Non Drinker-vs-Social Drinker
1.888360E-02
Daily Drinker-vs-Weekly Drinker
6.536800E-01
Daily Drinker-vs-Occasional Drinker
1.290990E-01
Daily Drinker-vs-Social Drinker
1.925160E-01
Weekly Drinker-vs-Occasional Drinker
7.082200E-02
Weekly Drinker-vs-Social Drinker
8.576200E-02
Occasional Drinker-vs-Social Drinker
8.189400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.039610E-01
Normal-vs-Grade 2
1.929810E-02
Normal-vs-Grade 3
2.571600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.741390E-01
Grade 1-vs-Grade 3
3.529200E-01
Grade 1-vs-Grade 4
1.039610E-01
Grade 2-vs-Grade 3
4.747800E-01
Grade 2-vs-Grade 4
1.929810E-02
Grade 3-vs-Grade 4
2.571600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.680790E-01
Normal-vs-NonDiabetic
5.713000E-01
Diabetic-vs-NonDiabetic
9.060300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.961400E-01
Normal-vs-NoPancreatitis
4.531000E-01
Pancreatitis-vs-NoPancreatitis
7.802600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.595200E-01
Normal-vs-N1
3.406800E-01
N0-vs-N1
2.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.706800E-01
Normal-vs-TP53-NonMutant
8.521000E-01
TP53-Mutant-vs-TP53-NonMutant
2.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
